Virtual Medicinal Product (VMP) - Brexucabtagene autoleucel 40million-200million cells/68ml dispersion for infusion bags

Navigation

Name Details

Name Start Date End Date
Name Current Name Brexucabtagene autoleucel 40million-200million cells/68ml dispersion for infusion bags Start Date 11-10-2022 End Date
Previous Name Previous Name Autologous anti-CD19-transduced CD3+ cells 40million-200million cells/68ml dispersion for infusion bags Start Date 09-02-2022 End Date 10-10-2022

Unit Dose & Form Information

DF Indicator
Discrete
UDFS Indicator
68.0
UDFS UOM
ml
Unit Dose UOM
bag

Summary

Prescribing Status
Valid as a prescribable product
Controlled Drug Category
No Controlled Drug Status
Route
Intravenous
Form
Dispersion for infusion
Ontology Form/Route
dispersioninfusion.intravenous
Name Basis
rINN - Recommended International Non-proprietary

Codes

ATC Code
L01XL06
SNOMED Codes
Code Start Date End Date
39362811000001101 03-02-2021

VMP Ingredients

VMP ingredients table
Name Basis of Strength Description BOSS Strength and UOM (Nmr) Strength and UOM (Dmr)
Brexucabtagene autoleucel Based on Ingredient Substance 1764706 cell 1 ml

Parent Products

Virtual Medicinal Product Pack (VMPP) Information

Pack Size Drug Tariff Price Drug Tariff Payment Category
1 bag